Paraflux Inc., a pharmaceutical company, reported earnings per share of €0.9, return on assets of 13%, a debt-to-equity ratio of 40%, a pre-tax interest rate of 8% and a retention ratio of 85% for the previous year. Moreover, the company had registered growth in earnings per share of 50% in the past five years. Assuming that the tax rate is 25% and that these figures will be sustained in the future, the expected growth rate in free cash flow to equity (FCFE) will be: a. 10.36% b. 16.53% c. 11.22% d. None of the given answers is correct. e. 13.43%